For years, testosterone replacement therapy (TRT) has carried a troubling reputation. Many men have heard warnings that raising testosterone levels could increase the risk of heart attacks, strokes, or other serious cardiovascular problems.
But as more high-quality research has become available, that narrative has changed. Today's evidence suggests that for men with clinically confirmed low testosterone, TRT does not increase the risk of heart attack, stroke, or death when prescribed and monitored appropriately. [endocrinep...actice.org], [acc.org]
Let's take a closer look at what the latest research actually says and what it means for men considering treatment.
Several years ago, a handful of observational studies raised questions about whether testosterone therapy might increase cardiovascular risk. Headlines quickly followed, leading many patients and providers to worry that TRT could do more harm than good.
The problem is that observational studies can identify associations, but they cannot prove cause and effect. Many participants in these studies were older adults with existing health conditions, making it difficult to determine whether testosterone therapy was actually responsible for adverse outcomes.
As a result, researchers called for larger, better-designed clinical trials to provide clearer answers.
Randomized controlled trials are considered the gold standard for evaluating treatment safety. Unlike observational studies, these trials compare treatment groups and control groups under carefully monitored conditions.
Over the past several years, researchers have completed larger and more rigorous analyses to determine whether testosterone therapy truly affects cardiovascular risk.
The results have been reassuring.
A recent meta-analysis examined 26 randomized controlled trials involving more than 10,000 men with hypogonadism, or clinically low testosterone levels. The goal was to evaluate whether testosterone replacement therapy increased the risk of major cardiovascular events. [endocrinep...actice.org]
Researchers analyzed outcomes including:
The analysis found no statistically significant increase in the risk of:
among men receiving testosterone therapy compared with those receiving placebo or standard treatment. [endocrinep...actice.org]
These findings are consistent with the large TRAVERSE Study, which followed more than 5,000 men with low testosterone and elevated cardiovascular risk. Researchers found that testosterone therapy did not increase the rate of major cardiovascular events compared with placebo. [acc.org], [health.harvard.edu]
Not all studies carry the same weight. When researchers combine data from multiple randomized controlled trials, they can often achieve a clearer and more reliable picture than any single study alone.
While no treatment is completely risk-free, current evidence suggests that appropriately prescribed testosterone therapy is not associated with a higher risk of heart attack or stroke in men with documented testosterone deficiency. [endocrinep...actice.org], [acc.org]
Low testosterone can affect far more than energy levels.
Symptoms may include:
Experiencing these symptoms doesn't automatically mean that testosterone levels are low, which is why proper testing is essential.
Many factors can cause symptoms similar to low testosterone, including stress, poor sleep, medications, and chronic health conditions.
Before prescribing TRT, physicians typically confirm low testosterone through laboratory testing and a clinical evaluation. This helps ensure treatment is directed toward the men most likely to benefit.
Testosterone therapy is generally considered when a patient has:
The goal is not to achieve superhuman hormone levels. Rather, treatment is designed to restore testosterone to a healthy range and improve quality of life.
Although concerns about heart attacks may be overstated, testosterone therapy still requires careful medical supervision.
Potential side effects can include:
Research has also noted increased rates of certain conditions, such as atrial fibrillation and pulmonary embolism, in some patient populations, highlighting the importance of individualized medical care and ongoing monitoring. [acc.org], [health.harvard.edu]
Patients receiving TRT should follow their physician's monitoring schedule, which may include:
Regular follow-up helps ensure treatment remains safe and effective over time.
The good news is that many health insurance plans cover testosterone replacement therapy when it is considered medically necessary.
Coverage requirements vary by insurer, but most plans require evidence that low testosterone has been properly diagnosed.
Many insurers require:
Because testosterone naturally fluctuates throughout the day, morning testing is usually required to obtain the most accurate measurement.
Some insurance carriers require prior authorization before approving treatment.
Patients may want to ask their physician:
Understanding these requirements upfront can help avoid delays and unexpected costs.
The belief that testosterone therapy causes heart attacks continues to circulate, but current research paints a much different picture.
Recent evidence, including a meta-analysis of 26 randomized controlled trials and the large TRAVERSE Study, found no increased risk of heart attack, stroke, cardiovascular death, or overall mortality among appropriately selected men receiving testosterone therapy for clinically confirmed low testosterone. [endocrinep...actice.org], [acc.org]
If you're experiencing symptoms of low testosterone, the best next step is a conversation with your healthcare provider.
With proper testing, medical oversight, and insurance verification, testosterone replacement therapy may be a safe and effective option for improving quality of life.
As always, decisions about treatment should be based on your individual health needs, not outdated myths.
Medical Disclaimer: This article is for informational and educational purposes only and should not be considered medical advice, diagnosis, or treatment. Testosterone replacement therapy (TRT) may not be appropriate for everyone, and treatment decisions should be made in consultation with a qualified healthcare provider who is familiar with your medical history, symptoms, and laboratory results. Never start, stop, or change any medication without first speaking with your physician.
Insurance coverage and prior authorization requirements vary by carrier, plan, state, and individual circumstances. Coverage information provided in this article is general in nature and should not be interpreted as a guarantee of benefits. Contact your insurance carrier or healthcare provider to verify your specific coverage requirements.
While current evidence suggests that TRT does not increase the overall risk of heart attack, stroke, cardiovascular death, or all-cause mortality in appropriately selected men with documented testosterone deficiency, individual risks may vary. Patients should discuss the potential benefits and risks of treatment with their healthcare team. [endocrinep...actice.org], [acc.org]